158959-56-9

Basic information

• Product Name: Benzenesulfonamide, 4-[2-(4-fluorophenyl)-4,4-dimethyl-1-cyclopenten-1-yl]-
• CAS NO: 158959-56-9
• Molecular Formula: C19H20FNO2S
• Molecular Weight: 345.438
• Mol File: 158959-56-9.mol
• Article Data: 16

Chemical Properties

• CAS DataBase Reference: Benzenesulfonamide, 4-[2-(4-fluorophenyl)-4,4-dimethyl-1-cyclopenten-1-yl]-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzenesulfonamide, 4-[2-(4-fluorophenyl)-4,4-dimethyl-1-cyclopenten-1-yl]-(158959-56-9)
• EPA Substance Registry System: Benzenesulfonamide, 4-[2-(4-fluorophenyl)-4,4-dimethyl-1-cyclopenten-1-yl]-(158959-56-9)

Safety Data

• Hazardous Substances Data: 158959-56-9(Hazardous Substances Data)

Upstream product

• 122-56-5 tributyl borane 
• 158959-43-4 1-(2-(4-fluorophenyl)4,4-dimethylcyclopenten-1-yl)-4-(methylsulfonyl)benzene 
• 2950-43-8 hydroxylamine-O-sulfonic acid 

Relevant articles and documents

METHOD OF USING CYCLOOXYGENASE-2 INHIBITORS IN THE TREATMENT AND PREVENTION OF NEOPLASIA

This invention relates to the use of cyclooxygenase-2 inhibitors or derivatives thereof in preventing and treating neoplasia. In particular, the invention describes the method of preventing and treating epithelial cell neoplasia in a subject, said method comprising treating the subject with a therapeutically-effective amount of a compound of Formula (I) wherein A, R and R are as described in the specification.

Use of a COX-2 inhibitor and a NK-1 receptor antagonist for treating inflammation

The present invention provides the use of a COX-2 inhibitior and an NK-1 receptor antagonist for the treatment or prevention of inflammatory disorders.

Combination of a GABAA alpha 5 inverse agonist and COX-2 inhibitor, NSAID, estrogen or vitamin E

Combinations of a GABAAalpha 5 inverse agonist and a COX-2 inhibitor, NSAID, estrogen or vitamin E are disclosed for treating neurodegenerative conditions such as Alzheimer's Disease.